文献速递临床试验与 GCP

不同治疗方式对伴下颌后缩的儿童OSAHS疗效的多中心随机对照试验研究方案

The efficacy of different treatment approaches for pediatric OSAHS patients with mandibular retrognathia: study protocol for a multicenter randomized controlled trial.
PubMed 文献 · Trials · 2020-06-30

本研究为多中心随机对照试验,计划纳入352例7至10岁伴下颌后缩的轻度OSAHS儿童,随机分为药物治疗组、手术治疗组、正畸治疗组及手术联合术后正畸组,于基线、治疗开始后7个月、12个月和24个月评估疗效,主要终点为阻塞性呼吸暂停低通气指数平均变化。

要点

  • 针对伴下颌后缩的轻度OSAHS儿童,比较药物、手术、正畸及手术联合正畸四种治疗方式的疗效。
  • 主要终点为阻塞性呼吸暂停低通气指数平均变化,随访至治疗开始后24个月。
  • 研究结果旨在为儿童OSAHS的多学科治疗提供长期疗效证据。

核心结论

  • 该随机对照试验旨在研究腺样体扁桃体切除术和/或正畸治疗对伴下颌后缩的轻度OSAHS儿童的疗效。
  • 研究结果将为不同治疗方式的优势和长期疗效提供证据,并促进儿童OSAHS的多学科治疗。

研究设计与样本

  • 多中心随机对照试验,计划纳入352例7至10岁伴下颌后缩的轻度OSAHS儿童。
  • 随机分为四组:药物治疗组、手术治疗组、正畸治疗组、手术联合术后正畸组。
  • 随机化后4周内接受治疗,于基线、治疗开始后7个月、12个月和24个月进行结局评估。

关键数值与推荐

  • 主要终点为阻塞性呼吸暂停低通气指数平均变化。
  • 其他终点包括多导睡眠监测评估的最低血氧饱和度、呼吸暂停指数和低通气指数。
  • 其他终点还包括OSA-20问卷评估的主观症状、头影测量分析和上气道形态学分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pediatric obstructive sleep apnea/hypopnea syndrome (OSAHS) is a multifactorial syndrome caused by many risk factors, such as craniofacial anomalies, adenotonsillar hypertrophy, obesity, and airway inflammation. Although new treatment patterns have recently been proposed, treatment methods for children remain particularly challenging and controversial. This randomized controlled trial was designed to investigate the efficacy of adenotonsillectomy and/or orthodontic treatment for children who have mild OSAHS with mandibular retrognathia. METHODS: A sample of 352 children with mild OSAHS and mandibular retrognathia, who are aged between 7 and 10 years, will be enrolled in the study. They will be randomized into four groups: the drug treatment group, the surgical treatment group, the orthodontic treatment group, or the surgery and postoperative orthodontic group. After randomization the children will receive treatments within 4 weeks. Outcome assessment will take place at the following points: (1) baseline, (2) 7 months after the treatment starting point, (3) 12 months after the treatment starting point, and (4) 24 months after the treatment starting point. The primary endpoint of the trial is the mean change in obstructive apnea/hypopnea index. Other endpoints will consist of the lowest oxygen saturation, apnea index, and hypopnea index assessed by polysomnography, subjective symptoms (assessed by the OSA-20 questionnaire), cephalometric measurements, and morphologic analysis of the upper airway. DISCUSSION: The results of this study will provide valuable evidence for the merits and long-term efficacy of different treatment approaches and contribute to facilitating the multidisciplinary treatment of pediatric OSAHS. TRIAL REGISTRATION: ClinicalTrials.gov : NCT03451318. Registered on 2 March 2018 (last update posted 19 April 2018).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Li Y, Wu J, Guo J, et al. The efficacy of different treatment approaches for pediatric OSAHS patients with mandibular retrognathia: study protocol for a multicenter randomized controlled trial. Trials. 2020. PMID: 32605655. doi:10.1186/s13063-020-04398-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。